[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Moore et al., 2018 - Google Patents

Neuropharmacology of compulsive eating

Moore et al., 2018

View HTML
Document ID
4929299024483010081
Author
Moore C
Panciera J
Sabino V
Cottone P
Publication year
Publication venue
Philosophical Transactions of the Royal Society B: Biological Sciences

External Links

Snippet

Compulsive eating behaviour is a transdiagnostic construct observed in certain forms of obesity and eating disorders, as well as in the proposed construct of 'food addiction'. Compulsive eating can be conceptualized as comprising three elements:(i) habitual …
Continue reading at royalsocietypublishing.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Similar Documents

Publication Publication Date Title
Moore et al. Neuropharmacology of compulsive eating
Pizzagalli Toward a better understanding of the mechanisms and pathophysiology of anhedonia: are we ready for translation?
Fukumoto et al. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2 R, 6 R)-hydroxynorketamine
Uhl et al. The neurobiology of addiction
Altarifi et al. Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents
Paul et al. Functional topography of serotonergic systems supports the Deakin/Graeff hypothesis of anxiety and affective disorders
Smith et al. Exercise as a potential treatment for drug abuse: evidence from preclinical studies
Egli et al. Alcohol dependence as a chronic pain disorder
Stanley et al. The interpersonal dimension of borderline personality disorder: toward a neuropeptide model
Stanford The open field test: reinventing the wheel
Mann et al. Acamprosate: recent findings and future research directions
Sherin et al. Post-traumatic stress disorder: the neurobiological impact of psychological trauma
Miranda et al. Glutamatergic activity in the amygdala signals visceral input during taste memory formation
Zhou et al. Oxytocin reduces cocaine seeking and reverses chronic cocaine-induced changes in glutamate receptor function
Pedersen Oxytocin, tolerance, and the dark side of addiction
Lynch et al. Trace amine associated receptor 1 modulates behavioral effects of ethanol
Cortese et al. Alertness and feeding behaviors in ADHD: does the hypocretin/orexin system play a role?
Zhang et al. Sex differences in nociceptin/orphanin FQ peptide receptor-mediated pain and anxiety symptoms in a preclinical model of post-traumatic stress disorder
Brown et al. Sex and dose-related differences in methylphenidate adolescent locomotor sensitization and effects on brain-derived neurotrophic factor
Carboni Peripheral biomarkers in animal models of major depressive disorder
Chen et al. Multiple ‘hits’ during postnatal and early adulthood periods disrupt the normal development of sensorimotor gating ability in rats
Rothwell et al. Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure
Clarke et al. The role of corticostriatal–hypothalamic neural circuits in feeding behaviour: implications for obesity
Vines et al. Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions
Lieving et al. Effects of acute tiagabine administration on aggressive responses of adult male parolees